Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2010
by University Hospital Inselspital, Berne.
Recruitment status was Recruiting
Study NCT01220375 Information provided by University Hospital Inselspital, Berne
First Received on October 11, 2010. Last Updated on October 12, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Myeloma
Additional conditions recognized in this trial
Multiple Myeloma
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
Plerixafor
Additional drug interventions recognized in this trial
JM 3100
Vinorelbine
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital Inselspital, Berne
Back to top of Main Content